Impact of new clinical trials on recent guidelines on hypertension management

References

• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, . 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, .; ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–59.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, .; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359:1225–37.
   PubMed Web of Science ®Google Scholar
• ; Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) InvestigatorsYusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, . Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008;372: 1174–83.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362:1575–85.
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, .; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, .; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, .; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–28.
   PubMed Web of Science ®Google Scholar
• Haller H, Ito S, Izzo JL, Januszewicz A, Katayama S, Menne J, . Prevention of microalbuminuria in type 2 diabetes (ROADMAP TRIAL). J Hypertens. 2010;28(e-suppl):e233.
   Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009; 27:2121–58.
   PubMed Web of Science ®Google Scholar
• Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res. 2005;2:105–12.
   PubMedGoogle Scholar
• Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113–32.
   PubMed Web of Science ®Google Scholar
• Mancia G, Lanfranchi A, Turri C, Grassi G. Can good surrogate end-points predict the prognosis of hypertensive patients? J Hypertens Suppl. 1998;16:S3–S7.
   Google Scholar
• Mancia G, Grassi G. The new European Society of Hypertension / European Society of Cardiology Guidelines. Ther Adv Cardiovasc Dis. 2008;2:5–12.
   Google Scholar
• Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, . Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345: 1291–7.
   PubMed Web of Science ®Google Scholar
• Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–53.
   PubMed Web of Science ®Google Scholar
• Verberk W, Kroon AA, de Leeuw PW. Masked hypertension and white-coat hypertension prognosis. J Am Coll Cardiol. 2006;47:2127.
   Google Scholar
• Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol. 2007;100: 3J–9J.
   Google Scholar
• Grassi G. Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options. Curr Hypertens Rep. 2003;5:277–80.
   PubMed Web of Science ®Google Scholar
• Hypertension: management of hypertension in adults in primary care NICE/BHS. June 2006. Available at: www.nice.org.uk/CG034.
   Google Scholar
• Sica DA. Chlorthalidone—a renaissance in use? Expert Opin Pharmacother. 2009;10:2037–9.
   PubMed Web of Science ®Google Scholar
• Neff KM, Nawarskas JJ. Hydrochlorothiazide versus chlorthalidone in the management of hypertension. Cardiol Rev. 2010;18:51–6.
   Google Scholar
• Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens. 2006;24:3–10.
   PubMed Web of Science ®Google Scholar
• Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L, . Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens. 2008;26:819–24.
   PubMed Web of Science ®Google Scholar
• Lever AF, Beevers DG, Hole DJ, Isles CG, Meredith PA, Murray LS, . Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why? Clin Exp Hypertens. 1999;21: 553–62.
   PubMed Web of Science ®Google Scholar
• Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ. 1998;317:167–71.
   PubMed Web of Science ®Google Scholar
• Mancia G. Role of outcome trials in providing information on antihypertensive treatment: importance and limitations. Am J Hypertens. 2006;19:1–7.
   PubMed Web of Science ®Google Scholar
• Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20: 1461–4.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A, . Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Intern Med. 2002;162:582–86.
   PubMedGoogle Scholar
• Mancia G, Pessina AC, Trimarco B, Grassi G; SILVIA (Studio Italiano Longitudinale sulla Valutazione della Ipertensione Arteriosa nel 2000) Study Group. Blood pressure control according to new guidelines targets in low to high-risk hypertensives managed in specialist practice. J Hypertens. 2004;22:2387–96.
   PubMed Web of Science ®Google Scholar
• Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M; ForLife study group. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens. 2005;23:1575–81.
   PubMed Web of Science ®Google Scholar
• Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, . Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens. 2006;24:837–43.
   PubMed Web of Science ®Google Scholar
• Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Baurecht H, . Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2007;25:1087–94.
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.
   PubMed Web of Science ®Google Scholar
• Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, .; LIFE Study Investigators. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Circulation. 2009;119:1883–91.
   PubMed Web of Science ®Google Scholar
• Li Z, Dahlöf B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, . Bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study. J Hypertens. 2008;26:1244–9.
   PubMed Web of Science ®Google Scholar
• Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, .; INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003; 290:2805–16.
   PubMed Web of Science ®Google Scholar
• Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, .; VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022–31.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Messerli FH, Wun C, Zuckerman AL, DeMicco D, Kostis JB, .; Treating to New Targets Steering Committee and Investigators. J-Curve revisited: an analysis of the Treating to New Targets (TNT) Trial. J Am Coll Cardiol. 2009;53:A217.
   Google Scholar
• Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, .; ACCOMPLISH Trial investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet. 2010;375:1173–81.
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, . ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813–21.
   PubMed Web of Science ®Google Scholar